Premium
Relationship of non‐alcoholic fatty liver disease to colorectal adenomatous polyps
Author(s) -
Hwang Sang Tae,
Cho Yong Kyun,
Park Jung Ho,
Kim Hong Joo,
Park Dong Il,
Sohn Chong Il,
Jeon Woo Kyu,
Kim Byung Ik,
Won Kyoung Hee,
Jin Wook
Publication year - 2010
Publication title -
journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.214
H-Index - 130
eISSN - 1440-1746
pISSN - 0815-9319
DOI - 10.1111/j.1440-1746.2009.06117.x
Subject(s) - medicine , gastroenterology , fatty liver , odds ratio , metabolic syndrome , colorectal cancer , adenomatous polyps , colonoscopy , insulin resistance , disease , cancer , obesity
Background and Aims: Metabolic syndrome and insulin resistance are associated with a higher risk of colon cancer. Non‐alcoholic fatty liver disease (NAFLD) is regarded as a manifestation of metabolic syndrome in the liver. This investigation was initiated to determine whether NAFLD has a relationship to colorectal adenomatous polyps. Methods: We examined the 2917 participants who underwent a routine colonoscopy at Kangbuk Samsung Hospital in 2007. We divided the 2917 subjects into the adenomatous polyp group ( n = 556) and the normal group ( n = 2361). Anthropometric measurements, biochemical tests for liver and metabolic function, and abdominal ultrasonographs were assessed. Results: The prevalence of NAFLD was 41.5% in the adenomatous polyp group and 30.2% in the control group. By multiple logistic regression analysis, NAFLD was found to be associated with an increased risk of colorectal adenomatous polyps (odds ratio, 1.28; 95% confidence interval, 1.03–1.60). An increased risk for NAFLD was more evident in patients with a greater number of adenomatous polyps. Conclusion: NAFLD was associated with colorectal adenomatous polyps. Further studies are needed to confirm whether NAFLD is a predictor for the development of colorectal adenomatous polyps and cancer.